- Home
- ANDG vs RXRX Comparison
ANDG vs RXRX Comparison
Compare ANDG & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANDG | RXRX |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ANDG | RXRX |
|---|---|---|
| Price | $28.26 | $3.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $30.83 | $7.50 |
| AVG Volume (30 Days) | 366.4K | ★ 11.4M |
| Earning Date | 03-17-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $16.02 | $12.11 |
| Revenue Next Year | $13.67 | $82.52 |
| P/E Ratio | $44.38 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $18.12 | $2.80 |
| 52 Week High | $30.22 | $7.18 |
Technical Indicators
Market Signals| Indicator | ANDG | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.50 | 49.36 |
| Support Level | $25.00 | $2.98 |
| Resistance Level | $30.22 | $5.03 |
| Average True Range (ATR) | 1.73 | 0.16 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 60.55 | 75.57 |
Price Performance
Historical ComparisonAbout ANDG Andersen Group Inc. Class A Common Stock
Andersen Group Inc is a provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.